Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

223
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
114.1(c) 118(c) 117.45(c) 117.8(c) 117.9 Last
1 528 356 4 656 964 2 418 424 2 036 031 1 766 827 Volume
+0.18% +3.42% -0.47% +0.30% +0.08% Change
More quotes
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
02/26Earnings Release
Surperformance© rating of Bayer AG
Trading Rating : Investor Rating :
More about the company
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 41 754 M
EBIT 2014 6 388 M
Net income 2014 3 853 M
Debt 2014 14 992 M
Yield 2014 1,89%
Sales 2015 45 465 M
EBIT 2015 7 347 M
Net income 2015 4 587 M
Debt 2015 14 436 M
Yield 2015 2,12%
PER 2014 25,33
PER 2015 21,89
EV / Sales 2014 2,69x
EV / Sales 2015 2,46x
Capitalization 97 414 M
More Financials
Latest news on BAYER AG
2d ago Bayer explores possible sale of diabetes device unit - Bloomberg
2d ago BAYER : FDA will speed review of 2 respiratory meds
2d ago BAYER CROPSCIENCE : opens Weed Resistance Competence Center in Frankfurt, German..
2d agoDJBayer Considering Sale of Diabetes Device Unit -Bloomberg
6d ago BAYER : CropScience opens Weed Resistance Competence Center in Frankfurt, German..
11/19 BAYER : solution for pesticide contamination
11/18 BAYER : solution for pesticide contamination
11/18 BAYER : increases its donations of medications for ebola patients to a total val..
11/18 BAYER : increases its donations of medications for ebola patients to a total val..
11/18 BAYER : acquires OTC drug firm Dihon for $586 million
11/17 BAYER : acquires OTC drug firm Dihon for $586 million
11/17 BAYER : acquires OTC drug firm Dihon for $586 million
More news
4-Traders Strategies on BAYER AG 
07/18The EUR 100 area as entry point
05/20The EUR 104 resistance as main obstacle
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF